• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:宗慧颖,张云迪,李越,李妍.基于基因检测和血药浓度监测技术优化肝移植术后他克莫司个体化给药方案[J].药学研究,2024,43(2):194-199[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 3087次   下载 2703次 本文二维码信息
码上扫一扫!
基于基因检测和血药浓度监测技术优化肝移植术后他克莫司个体化给药方案
宗慧颖1,2,张云迪1,2,李越2,李妍2
字体:加大+|默认|缩小-
(1.山东中医药大学,山东 济南 250355;2.山东第一医科大学第一附属医院<山东省千佛山医院>,山东 济南 250014)
摘要:
他克莫司是广泛应用于临床的钙调神经磷酸酶类抑制剂,被作为肝移植术后预防和治疗急性排斥反应的一线药物。然而,在临床应用中,他克莫司表现出治疗窗口窄、药动学个体差异大等特点,移植后早期低浓度的他克莫司可能会诱发排斥反应;而高浓度的他克莫司可能会导致肾毒性和/或神经毒性,因此对于他克莫司药动学的影响因素进行深入研究至关重要。本文通过检索中国知网(CNKI)、维普、万方以及PubMed数据库,综述了临床上对患者实行基因检测和血药浓度监测的必要性,得出根据基因多态性进行给药以及寻找替代药时曲线下面积的最佳采样点策略可能将有助于临床医生对他克莫司的最佳起始剂量进行预测,进而帮助调整维持方案,且有望减少不良反应的发生。
关键词:  肝移植  他克莫司  基因检测  血药浓度监测
DOI:10.13506/j.cnki.jpr.2024.02.016
基金项目:山东省医学会齐鲁专项(No.YXH2022ZX02048)
Optimization of individualized tacrolimus dosing regimen after liver transplantation based on genetic testing and blood concentration monitoring techniques
ZONG Huiying1,2,ZHANG Yundi1,2,LI Yue2,LI Yan2
(1. Department of Pharmacy, Shandong University of Traditional Chinese Medicine, Department of Pharmacy, Shandong Provincial Qianfoshan Hospital Jinan 250355, China; 2. Clinical Pharmacy, the First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan 250014, China)
Abstract:
Tacrolimus, a widely used clinical calcium-modulated neural phosphatase inhibitor, is used as a first-line agent for the prevention and treatment of acute rejection after liver transplantation. However, in clinical applications, tacrolimus exhibits a narrow therapeutic window and large individual differences in pharmacokinetics, and low concentrations of tacrolimus in the early post-transplant period may induce rejection; whereas high concentrations of tacrolimus may lead to nephrotoxicity and/or neurotoxicity, so in-depth studies on the factors influencing the pharmacokinetics of tacrolimus are essential. In this article, we reviewed the clinical need for genetic testing and blood concentration monitoring in patients by searching the Chinese Network of Knowledge (CNKI), Wipro, Wanfang, and PubMed databases, and concluded that dosing based on genetic polymorphisms and the strategy of finding the optimal sampling point of the area under the curve at the time of substitution may be helpful to clinicians in predicting the optimal starting dosage of tacrolimus, which can help in the adjustment of the maintenance regimen, and is expected to reduce the incidence of adverse effects.
Key words:  Liver transplantation  Tacrolimus  Genetic testing  Blood concentration monitoring
今日访问量:2490    总访问量:55338932
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司